Acrivon Therapeutics, Inc.
ACRV
Revenue
0.00
0.000.00%
-Assets
145.30M
▼-13.28M▼-8.38%
3 Months ChangeLiabilities
16.70M
▲1.15M▲7.40%
3 Months ChangeFree Cash Flow
-19.59M
▼-1.70M▼-9.47%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-02
Form 8-K
ID: 0001193125-26-085516
2026-02-27
Form 8-K
ID: 0001193125-26-079500
2026-01-08
Form 8-K
ID: 0001193125-26-007077
2026-01-08
Form 8-K
ID: 0001193125-26-007007
2025-11-13
Form 10-Q
ID: 0001193125-25-280215
2025-11-13
Form 8-K
ID: 0001193125-25-280172
2025-09-05
Form 8-K
ID: 0001193125-25-197250
2025-08-13
Form 10-Q
ID: 0000950170-25-108054
2025-08-13
Form 8-K
ID: 0001193125-25-179834
2025-06-13
Form 8-K
ID: 0000950170-25-086246